BIBF 1120 (nintedanib), a triple angiokinase inhibitor, induces hypoxia but not EMT and blocks progression of preclinical models of lung and pancreatic cancer. (Q36927086)
Jump to navigation
Jump to search
scientific article published on 31 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BIBF 1120 (nintedanib), a triple angiokinase inhibitor, induces hypoxia but not EMT and blocks progression of preclinical models of lung and pancreatic cancer. |
scientific article published on 31 May 2013 |
Statements
BIBF 1120 (nintedanib), a triple angiokinase inhibitor, induces hypoxia but not EMT and blocks progression of preclinical models of lung and pancreatic cancer (English)
Bercin Kutluk Cenik
Katherine T Ostapoff
1 reference
1 reference
1 reference
1 reference
1 reference